558
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Working Conditions, Work Productivity, Quality of Life, and Depressive Symptoms in Undiagnosed Adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms During the COVID-19 Pandemic

ORCID Icon, ORCID Icon, , , , , , & show all
Pages 1561-1572 | Received 18 Feb 2022, Accepted 06 Jul 2022, Published online: 29 Jul 2022

References

  • American Psychiatric Association, DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™. 5th ed. Arlington, VA: American Psychiatric Publishing, Inc; 2013.
  • Joseph A, Kosmas CE, Patel C, Doll H, Asherson P. Health-related quality of life and work productivity of adults with ADHD: a U.K. web-based cross-sectional survey. J Atten Disord. 2019;23(13):1610–1623.
  • Pitts M, Mangle L, Asherson P. Impairments, diagnosis and treatments associated with attention-deficit/hyperactivity disorder (ADHD) in UK adults: results from the lifetime impairment survey. Arch Psychiatr Nurs. 2015;29(1):56–63.
  • Kirino E, Imagawa H, Goto T, Montgomery W. Sociodemographics, comorbidities, healthcare utilization and work productivity in Japanese patients with adult ADHD. PLoS One. 2015;10(7):e0132233.
  • Shigemura J, Kurosawa M. Mental health impact of the COVID-19 pandemic in Japan. Psychol Trauma. 2020;12(5):478–479.
  • Nagasu M, Muto K, Yamamoto I. Impacts of anxiety and socioeconomic factors on mental health in the early phases of the COVID-19 pandemic in the general population in Japan: a web-based survey. PLoS One. 2021;16(3):e0247705.
  • Yamamoto T, Uchiumi C, Suzuki N, Yoshimoto J, Murillo-Rodriguez E. The psychological impact of ‘mild lockdown’ in Japan during the COVID-19 pandemic: a nationwide survey under a declared state of emergency. Int J Environ Res Public Health. 2020;17(24):9382.
  • Ueda M, Stickley A, Sueki H, Matsubayashi T. Mental health status of the general population in Japan during the COVID-19 pandemic. Psychiatry Clin Neurosci. 2020;74(9):505–506.
  • Nomura S, Kawashima T, Yoneoka D, et al. Trends in suicide in Japan by gender during the COVID-19 pandemic, up to September 2020. Psychiatry Res. 2021;295:113622.
  • Ueda M, Nordström R, Matsubayashi T. Suicide and mental health during the COVID-19 pandemic in Japan. J Public Health. 2021;1:548.
  • Zhang J, Shuai L, Yu H, et al. Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak. Asian J Psychiatr. 2020;51:102077.
  • Shah R, Raju VV, Sharma A, Grover S. Impact of COVID-19 and lockdown on children with ADHD and their families—an online survey and a continuity care model. J Neurosci Rural Pract. 2021;12(1):71–79.
  • Melegari MG, Giallonardo M, Sacco R, Marcucci L, Orecchio S, Bruni O. Identifying the impact of the confinement of Covid-19 on emotional-mood and behavioural dimensions in children and adolescents with attention deficit hyperactivity disorder (ADHD). Psychiatry Res. 2021;296:113692.
  • Bobo E, Lin L, Acquaviva E, et al. Comment les enfants et adolescents avec le trouble déficit d’attention/hyperactivité (TDAH) vivent-ils le confinement durant la pandémie COVID-19? [How do children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) experience lockdown during the COVID-19 outbreak?]. L’Encéphale. 2020;46(Supplement 3):S85–92.
  • Breaux R, Dvorsky MR, Marsh NP, et al. Prospective impact of COVID-19 on mental health functioning in adolescents with and without ADHD: protective role of emotion regulation abilities. J Child Psychol Psychiatry. 2021;62:1132–1139.
  • Behrmann JT, Blaabjerg J, Jordansen J. Jensen de López KM. Systematic review: investigating the impact of COVID-19 on mental health outcomes of individuals with ADHD. J Atten Disord. 2022;26(7):959–975.
  • Hollingdale J, Adamo N, Tierney K. Impact of COVID-19 for people living and working with ADHD: a brief review of the literature. AIMS Public Health. 2021;8(4):581–597.
  • Engel-Yeger B. Emotional status and quality of life in women with ADHD during COVID-19. OTJR (Thorofare N J). 2022. doi:10.1177/15394492221076516
  • Pollak Y, Shoham R, Dayan H, Gabrieli-Seri O, Berger I. Symptoms of ADHD predict lower adaptation to the COVID-19 outbreak: financial decline, low adherence to preventive measures, psychological distress, and illness-related negative perceptions. J Atten Disord. 2022;26(5):735–746.
  • Adamou M, Fullen T, Galab N, et al. Psychological effects of the COVID-19 imposed lockdown on adults with attention deficit/hyperactivity disorder: cross-sectional survey study. JMIR Form Res. 2020;4(12):e24430.
  • Nakamura S, Ohnishi M, Uchiyama S. Epidemiological survey of adult attention deficit hyperactivity disorder (ADHD) in Japan. Jpn J Psychiatr Treat. 2013;28:155–162.
  • Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–409.
  • Corominas-Roso M, Palomar G, Ferrer R, et al. Cortisol response to stress in adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2015;18(9):pyv027.
  • Kessler RC, Adler L, Ames M, et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256.
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
  • Shiroiwa T, Fukuda T, Ikeda S, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707–719.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353–365.
  • Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
  • Muramatsu K, Kamijima K, Yoshida M, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep. 2007;101(3 Pt 1):952–960.
  • Kawohl W, Nordt C. COVID-19, unemployment, and suicide. Lancet Psychiatry. 2020;7(5):389–390.
  • Fukai T, Ichimura H, Kawata K. Describing the impacts of COVID-19 on the labor market in Japan until June 2020. Jpn Econ Rev. 2021;72(3):439–470.
  • Statistics Bureau of Japan. Tokyo: Labour Force Survey; 2021. Available from: https://www.stat.go.jp/english/data/roudou/index.html. Accessed August 8, 2021.
  • Montano B. Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004;65:18–21.
  • Japan Ministry of Health Labour and Welfare. Overview of 2018 Employment Trend Survey Results. https://www.mhlw.go.jp/toukei/itiran/roudou/koyou/doukou/19-2/dl/gaikyou.pdf2018. Accessed July 8, 2022.
  • Pawaskar M, Fridman M, Grebla R, Madhoo M. Comparison of quality of life, productivity, functioning and self-esteem in adults diagnosed with ADHD and with symptomatic ADHD. J Atten Disord. 2020;24(1):136–144.
  • Cossrow N, Pawaskar M, Witt EA, et al. Estimating the prevalence of binge eating disorder in a community sample from the United States: comparing DSM-IV-TR and DSM-5 criteria. J Clin Psychiatry. 2016;77(8):e968–974.
  • Ando M, Takeda T, Kumagai K. A qualitative study of impacts of the COVID-19 pandemic on lives in adults with attention deficit hyperactive disorder in Japan. Int J Environ Res Public Health. 2021;18(4):2090.
  • Umishio W, Kagi N, Asaoka R, Hayashi M, Sawachi T, Ueno T. Work productivity in the office and at home during the COVID-19 pandemic: a cross-sectional analysis of office workers in Japan. Indoor Air. 2021.
  • Kuriyan AB, Pelham WE, Molina BS, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. J Abnorm Child Psychol. 2013;41(1):27–41.
  • Ishizuka K, Ishiguro T, Nomura N, Inada T. Depressive mood changes are associated with self-perceptions of ADHD characteristics in adults. Psychiatry Res. 2021;300:113893.